glp-1 receptor agonists in pediatric and adolescent obesity for the treatment of children adolescents: a meta-analysis of randomized controlled trials Current Insights, Advantages and Challenges
Description
Sarcopenia, or the age-related progressive loss of muscle mass and strength, has serious implications and is becoming more prevalent
There appear to be multiple pathways that GLP-1 agonists directly and indirectly target that cause a multitude of downstream effects in terms of immune, inflammatory and cellular health as Ive just highlighted
Krispy Kreme Downgraded on Worry Ozempic Will Hit Demand
The rapidly expanding market for GLP-1 receptor agonists may also be enticing more generic firms to take on risk when challenging patents
As with all things in biotech, the future is profoundly uncertain, and progress will always have roadblocks
